Derik Cooley-Downs

Director, Commercial Operations at Blueprint Medicines

Derik Cooley-Downs has a diverse work experience spanning over two decades in various roles within the pharmaceutical and financial sectors. Derik is currently working at Blueprint Medicines as the Director of Commercial Operations. Prior to this, Derik worked at Alexion Pharmaceuticals, Inc. as an Associate Director of Incentive Compensation. Derik also held the position of Associate Director of Field Analytics at Sage Therapeutics, where they played a crucial role in the launch of the company's inaugural product. Derik's experience at Takeda Oncology includes roles as an Associate Director of Business Analytics and Senior Manager of Business Analytics. Derik started their career as a Financial Analyst at BearingPoint and later worked as a Contract Analyst. Derik holds a position as the Financial Reporting and Measurements Specialist at TAC Worldwide Companies. Throughout their career, they have been responsible for designing and implementing incentive compensation plans, overseeing sales reporting and analysis, and managing non-cash reward programs.

Derik Cooley-Downs completed their Master of Business Administration (MBA) from Suffolk University - Sawyer Business School in the years 2007 to 2009. Prior to that, they obtained a Bachelor of Arts (BA) in American Politics from the University of Virginia from 1996 to 2000.

Links

Previous companies

Sage Therapeutics logo
Takeda Oncology logo
Alexion Pharmaceuticals logo
BearingPoint logo

Timeline

  • Director, Commercial Operations

    January, 2024 - present

  • Associate Director, Commercial Operations

    March, 2021